April 3, 2012
In response to advances in drug development and personalized medicine using genomic pharmacology, the Pharmaceuticals and Medical Devices Agency (PMDA) has strengthened since April 1 its consultation system with respect to pharmacogenomics (PGx) and biomarkers (BMs). In addition to establishing...read more